- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03320213
Value of CA125 and Yolk Sac Morphology in Prediction of Pregnancy Outcome in Threatened Miscarriage
October 20, 2017 updated by: Fatma Ahmed Mahmoud Sami, Ain Shams University
evaluation of serum CA125 level and yolk sac morphology in women with threatened miscarriage is very important to predict pregnancy outcome
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
192
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Pregnant women at age of 20- 40 years Pregnancy at 6-10 weeks women with single intrauterine spontaneous pregnancy
Description
Inclusion Criteria:
- pregnant women between 20-40 years. Pregnancy between 6-10 weeks. single intrauterine spontaneous pregnancy. vaginal bleeding or bloody vaginal discharge with or without pelvic pain for patients with threatened miscarriage.
Exclusion Criteria:
- medical disorders with pregnancy. History of recurrent miscarriage. Any maternal disease that would cause an increase in CA125 level. Local gynecological disorders e.g. fibroid. Presence of any uterine malformation. History of congenital abnormalities in previous pregnancy Presence of multiple pregnancy. Presence of anembryonic sac. Absent fetal heart pulsation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of serum CA125
Time Frame: 6 - 10 weeks
|
Measuring serum level of CA125 by ELIZA kits.
|
6 - 10 weeks
|
Evaluation of yolk sac morphology
Time Frame: 6 - 10 weeks
|
Evaluating yolk sac size and shape by transvaginal ultrasound
|
6 - 10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
follow up of participants
Time Frame: up to 20 weeks
|
measuring fetal heart rate by transvaginal ultrasound.
|
up to 20 weeks
|
follow up of participants
Time Frame: up to 20 weeks.
|
measuring crown rump length by transvaginal ultrasound.
|
up to 20 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2016
Primary Completion (ACTUAL)
July 30, 2017
Study Completion (ACTUAL)
July 30, 2017
Study Registration Dates
First Submitted
October 8, 2017
First Submitted That Met QC Criteria
October 20, 2017
First Posted (ACTUAL)
October 25, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 25, 2017
Last Update Submitted That Met QC Criteria
October 20, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 136
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Threatened Miscarriage in First Trimester
-
IBSA Institut Biochimique SATerminated
-
Hospital de Clinicas de Porto AlegreCompletedMiscarriage in First TrimesterBrazil
-
Imperial College LondonRecruitingMiscarriage in First TrimesterUnited Kingdom
-
Central Hospital, Nancy, FranceCompletedAbortion in First Trimester | Abortion, Second Trimester
-
King's College Hospital NHS TrustCompletedMiscarriage in First TrimesterUnited Kingdom
-
University of California, San DiegoRecruiting
-
Stanford UniversityGynuity Health ProjectsTerminated
-
KK Women's and Children's HospitalRecruitingAbortion in First TrimesterSingapore
-
Washington University School of MedicineCompletedAbortion in First TrimesterUnited States
-
University of Cape TownKarolinska Institutet; University of California, San Francisco; Grand Challenges...Recruiting